IMATIFLOW 400 MG - Steris Healthcare PVT LTD

IMATIFLOW 400 MG

Imatinib IP (400mg)

IMATIFLOW 400 MG is a potent medication containing Imatinib IP at a dosage of 400mg. This formulation is specifically designed for targeted cancer therapy, inhibiting the activity of certain proteins involved in cancer cell growth and proliferation. Let's delve into the features, benefits, and usage guidelines for IMATIFLOW 400 MG in the treatment of cancer.

Key Features and Benefits

• Targeted Cancer Therapy: Imatinib IP in IMATIFLOW 400 MG targets specific proteins, such as BCR-ABL tyrosine kinase, platelet-derived growth factor receptor (PDGFR), and c-kit, which are implicated in the growth and survival of cancer cells.
• Management of Various Cancers: IMATIFLOW 400 MG is used in the treatment of chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GISTs), and other cancers where these targeted proteins play a crucial role.
• Oral Administration: IMATIFLOW 400 MG is available in tablet form for convenient oral administration.

Indications for Use

IMATIFLOW 400 MG is indicated for the treatment of the following conditions:

• Chronic Myeloid Leukemia (CML): IMATIFLOW 400 MG is effective in the management of CML, especially in patients with the BCR-ABL fusion gene.
• Gastrointestinal Stromal Tumors (GISTs): IMATIFLOW 400 MG is used in the treatment of GISTs that are positive for the c-kit protein.
• Other Cancers: In certain cases, IMATIFLOW 400 MG may be prescribed for other cancers where targeted inhibition of specific proteins is beneficial.

Dosage and Administration

The recommended dosage of IMATIFLOW 400 MG (Imatinib IP 400mg) may vary depending on the type of cancer being treated and individual patient factors. It is typically taken orally once daily with a meal and a full glass of water. Follow your healthcare provider's instructions regarding dosage and duration of treatment.

Conclusion

IMATIFLOW 400 MG containing Imatinib IP (400mg) offers targeted therapy for various cancers by inhibiting specific proteins involved in cancer cell growth. With its oral tablet formulation and proven efficacy, IMATIFLOW 400 MG plays a crucial role in the management of chronic myeloid leukemia, gastrointestinal stromal tumors, and other cancers where targeted inhibition is beneficial. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

 For further information: 

  EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 BUY NOW